Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection

被引:9
作者
BergCandolfi, M
Candolfi, E
机构
[1] Institut de Parasitologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg
关键词
Toxoplasma infection; erythromycin; azithromycin; clarithromycin; clindamycin; N-demethylation; cytochrome P450 3A; mouse; liver; intestine;
D O I
10.1016/S0020-7519(96)00111-7
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The N-demethylation of macrolides was studied in a murine model of infection. Mice were infected with a cystogenic strain of Toxoplasma gondii (20 or 40 cysts/mouse) and microsomes were prepared from liver homogenates and jejunum villus tip enterocytes on day 10 post-infection. The rate of N-demethylation of the anti-Toxoplasma macrolides azithromycin, clarithromycin and clindamycin was investigated and compared to that of the macrolide erythromycin, a marker of the activity of the cytochrome P-450 3A (CYP3A) mono-oxygenases. In infected mice (20 cysts/mouse), the rate of N-demethylation fell in the liver and jejunum for erythromycin (- 25% and - 35%, respectively), azithromycin (- 12% and - 10%, respectively), clarithromycin (- 23% and - 21%, respectively) and clindamycin (- 20% and - 28%, respectively). The degree of hepatic depression was more marked in mice receiving a 40-cysts burden: for erythromycin (- 54%), azithromycin (- 29%), clarithromycin (- 49%) and clindamycin (- 47%). Copyright (C) 1996 Australian Society for Parasitology. Published by Elsevier Science Ltd.
引用
收藏
页码:1321 / 1323
页数:3
相关论文
共 22 条
[11]   TREATMENT OF TOXOPLASMIC ENCEPHALITIS WITH INTRAVENOUS CLINDAMYCIN [J].
DANNEMANN, BR ;
ISRAELSKI, DM ;
REMINGTON, JS .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (11) :2477-2482
[12]   PYRIMETHAMINE-CLARITHROMYCIN COMBINATION FOR THERAPY OF ACUTE TOXOPLASMA ENCEPHALITIS IN PATIENTS WITH AIDS [J].
FERNANDEZMARTIN, J ;
LEPORT, C ;
MORLAT, P ;
MEYOHAS, MC ;
CHAUVIN, JP ;
VILDE, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2049-2052
[13]  
FERRERO JL, 1990, DRUG METAB DISPOS, V18, P441
[14]   CLARITHROMYCIN CLINICAL PHARMACOKINETICS [J].
FRASCHINI, F ;
SCAGLIONE, F ;
DEMARTINI, G .
CLINICAL PHARMACOKINETICS, 1993, 25 (03) :189-204
[15]  
HOFFLIN JM, 1986, ANTIMICROBIOL, V31, P492
[16]  
KANATANI MS, 1994, WESTERN J MED, V160, P31
[17]   CLARITHROMYCIN-MINOCYCLINE COMBINATION AS SALVAGE THERAPY FOR TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
LACASSIN, F ;
SCHAFFO, D ;
PERRONNE, C ;
LONGUET, P ;
LEPORT, C ;
VILDE, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :276-277
[18]   THE COLORIMETRIC ESTIMATION OF FORMALDEHYDE BY MEANS OF THE HANTZSCH REACTION [J].
NASH, T .
BIOCHEMICAL JOURNAL, 1953, 55 (03) :416-421
[19]   AZITHROMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY [J].
PETERS, DH ;
FRIEDEL, HA ;
MCTAVISH, D .
DRUGS, 1992, 44 (05) :750-799
[20]  
SANDE MA, 1993, PHARMACOL BASIS THER, P117